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Medical errors are not uncommon, and they may cause patient 
morbidity and mortality and significantly increase health care costs. 
In 1999, it was estimated that up to 98 000 Americans might have 
died annually as a result of medical errors.1 Drug administration 
errors are significant contributors to this problem. The risk of errors 
in anaesthesia may be higher than other specialties.2 An anaesthetist 
may administer a quarter of a million drugs during his or her 
professional career,3 many of these extremely potent drugs, frequently 
administered within a brief period.
For many years – and more particularly in recent years – the 
anaesthetic literature has been concerned about drug errors in 
anaesthesia. Several solutions have been suggested to decrease the 
problem;4-10 these include educating and raising awareness about 
medication safety, reading and re-reading labels on drug ampoules, 
checking the ampoule label with a second person or device (e.g. 
bar code reader), labelling all syringes in theatre, adhering to the 
international standard of colour-coded syringe labels, improving the 
organisation of drug drawers and work space, informing anaesthetists 
of new formulations or packaging of drugs, and establishing a 
mechanism for reporting and reviewing errors.
In this issue of the SAMJ, Labuschagne et al. report on errors in 
drug administration by anaesthetists in public hospitals in the Free 
State province.11 They confirm the problem of drug administration 
errors in anaesthesia, with nearly 40% of respondents admitting 
to making a drug administration error at some stage in their 
career. Their investigation, which polled full-time and occasional 
anaesthetic providers, supports the 90% incidence of responders 
reporting errors in previous South African surveys.12,13 An expected 
finding in surveys of this nature is that a longer, full-time career in 
the specialty is more likely to be associated with a higher incidence 
of errors. This type of survey is useful to measure the occurrence 
of uncommon but potentially severe consequences, as it measures 
errors in very large numbers of cases, but lacks a denominator.14 
More accurate evidence on the actual incidence of drug errors during 
the delivery of anaesthetics is available from prospective studies 
such as that of 30 412 anaesthetics conducted in 3 South African 
teaching hospitals. The latter demonstrated a minimum incidence, 
of an error or near-miss, of 1 in every 274 anaesthetics administered, 
equating to approximately 6 incidents per month in each hospital.15 
This figure is in keeping with a prospective study from New Zealand 
that demonstrated an incidence of errors of 1:133 anaesthetics.16 
Another study from New Zealand suggests that by scanning bar 
codes on ampoules with a visual and auditory prompt to identify 
the drugs before drawing them up, together with conventional 
solutions suggested above, the rate of drug errors may be reduced by 
approximately a third.17
Although most errors do not result in major morbidity or death, 
a significant number can potentially seriously harm patients, e.g. 
wrong site injections such as that documented by Labuschagne, 
where a patient was left with serious neurological damage. Accidental 
administration of vasopressors may be the error with the greatest 
potential to contribute to morbidity and mortality. In the study 
by Labuschagne, 4 errors (12.2%) were due to the inadvertent 
administration of adrenaline instead of atropine or fentanyl. Although 
no adverse consequences were reported, subtle organ damage cannot 
be excluded. That one of the most common errors in this study 
remains the substitution of suxamethonium for fentanyl, indicates 
the poor response in South Africa to publications identifying the 
problem, highlighting causative factors, and suggesting preventive 
measures.10,18
Labuschagne’s work confirms earlier surveys that anaesthetists in 
South Africa would like a formal mechanism for reporting errors 
to be implemented.13 The majority identified the South African 
Society of Anaesthesiologists (SASA) as the preferred organisation 
to take responsibility for this task. The procedure could take the 
form of an online, anonymous reporting system freely accessible 
to all anaesthetic providers. Data collected nationally should be 
used to identify the causes of errors and provide a rational basis for 
instituting remedial action.
Poor ampoule labelling remains a major cause of substitution 
errors. Gordon suggested in 2004 that SASA should be involved with 
the pharmaceutical industry to improve and standardise ampoule 
labels. Despite approaches to the South African Bureau of Standards 
(SABS), by SASA, very little has been achieved in this regard.
Drug-class-specific colour-coded syringe labels are used 
internationally to reduce errors. In 2009, the SABS approved a 
new standard for colour-coded syringe labelling in theatres (SANS 
26825:2009) in line with the international ISO standard. The standard 
provides recommendations for the colour, size, design, general 
properties and typographical characteristics of the labels, and can 
be ordered from the SABS website https://www.sabs.co.za.19 It is 
disappointing to note that less than a quarter of respondents in the 
current survey were aware of the South African standard, and only a 
quarter of these made regular use of it.
Labuschagne’s study highlights the lack of any co-ordinated response 
by clinicians and managers to address the repeatedly documented 
occurrence of preventable drug administration errors on patients in 
operating theatres in South Africa. It is time for medical schools, SASA, 
the Department of Health, and the Medicines Control Council, together 
with pharmaceutical companies, the SABS, anaesthetic providers, and 
public and private hospitals to work together and take the necessary 
steps to prevent and reduce these errors.
Undergraduates at medical schools should receive lectures in patient 
safety as part of their curriculum. The possibility of medication errors 
and how to prevent them should also be emphasised during intern 
and registrar training.
Colour-coded syringe labels meeting the SABS standard should be 
available in all operating theatres throughout South Africa. While the 
efficacy of colour coding labels may still be the subject of debate, there is 
growing evidence that they contribute to patient safety and may decrease 
the danger of substitution errors from a different drug class.17
Both private sector and state sector drug procurement agencies 
should engage pharmaceutical companies to improve the standard 
of ampoule labelling and recognition. The technology exists in South 
Africa to consider bar coding of ampoules and employing the use 
of computer-generated audio and visual prompts, as advocated by 
Merry and Webster.9,17 South Africa must develop a standard for 
ampoule labelling similar to that adopted in the USA and Canada. 
This will require collaboration between the SABS, Medicines Control 
Council and the pharmaceutical industry.
The time has come to start implementing the necessary steps to 
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